PANIC Spring Webinar
As the importance and number of Oligonucleotide therapeutics grows, so too does the need for characterization methodologies both during drug development and production. Because structure is so intricately entwined in therapeutic efficacy for this class of drug, detailed characterization of structure is critical. Nuclear Magnetic Resonance (NMR) can deliver detailed structural information that spans the breadth of the different oligonucleotide-base therapies being developed. This webinar will detail some of the latest advancements in NMR oligonucleotide-based drug characterization.
Tuesday, 12 March 2024, 11:00 ES
Celestine Chi
Biophysics, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden
Robert Brinson
Research Chemist in the Biomolecular Structure and Function Group at the Institute for Bioscience and Biotechnology Research (IBBR), a joint research institute of the University of Maryland and NIST, in Rockville, Maryland
Dr. Martial Piotto
Pharma product manager of Biologics solutions